Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1Global Biodefense StaffApril 26, 2026
Medical Countermeasures UK Launches Phase 3 Trial of mRNA H5N1 Vaccine in Bid to Get Ahead of Next PandemicGlobal Biodefense StaffApril 23, 2026
AstraZeneca and Broad Institute Partner To Advance Antibacterials and Antivirals Antimicrobial Resistance September 17, 2012 …
FDA Grants Priority Review for Multi-Drug Resistant Tuberculosis Treatment Medical Countermeasures September 6, 2012 …
Biodefense BAA Supports Adjuvant Development for Emerging Diseases Contracts + Grants August 16, 2012 …
InBios, UN-Reno Partner to Develop Diagnostic for Melioidosis Medical Countermeasures August 9, 2012 …
DARPA Program Hits Milestone in Plant-Based Vaccines for Pandemics Medical Countermeasures July 28, 2012 …
